The Pharma Data
OCTOBER 15, 2020
The problem is, there’s no evidence that CBD is an effective treatment for these ailments. A random sample of 376 posts labeled testimonials found that 90% cited using CBD to treat diagnosable medical conditions. Nearly two-thirds of the testimonials discussed its use for treating mental or emotional problems.
The Pharma Data
NOVEMBER 17, 2020
At the suggestion of chairman Man-hee Lee, the prayer meeting was organized to end COVID-19 in the global village along with the development of effective and rapid treatment ahead of the massive plasma donation of some 4,000 Shincheonji Church of Jesus congregation members who have completely recovered.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PLOS: DNA Science
OCTOBER 19, 2023
Also recently, FDA’s Cellular, Tissue, and Gene Therapies Advisory Committe turned down a stem cell treatment for amyotrophic lateral sclerosis, aka ALS, Lou Gehrig’s disease, or motor neuron disease. The only treatment for ALS is a drug, Riluzole , taken as a tablet or a film. The pace though varies quite a lot.
The Pharma Data
OCTOBER 9, 2021
Food and Drug Administration (FDA) for the treatment of people living with Alzheimer’s fever ( Notice). This Refinement Therapeutic Designation reinforces our confidence in gantenerumab, which would be the first subcutaneous specific for the treatment of Alzheimer’s trouble with the prospect for at- home administration.”
Agency IQ
DECEMBER 11, 2023
The settlement would fund monitoring and remediation efforts for PFAS treatment for covered municipalities and cities. About $3 million would be paid by 3M with an addition $500,000 form DuPont which would cover “more than half” of the price tag of the treatment for a specific well.
Agency IQ
JULY 13, 2023
In June, the House Committee on Energy and Commerce (E&C) held a hearing on the House’s initial proposal , featuring testimony from witnesses and some legislative proposals for discussion. Congress is already working on the reauthorization process.
Agency IQ
JUNE 29, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94
Expert insights. Personalized for you.
52 
Let's personalize your content